v3.25.2
Segment reporting (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2025
CHF (SFr)
Jun. 30, 2024
CHF (SFr)
Jun. 30, 2025
CHF (SFr)
segment
Jun. 30, 2024
CHF (SFr)
Dec. 31, 2024
CHF (SFr)
Segments          
Number of segments | segment     1    
Collaborative research funding   SFr 115,277   SFr 348,757  
Fair value of services received at zero cost from Neurosterix Group SFr 34,505   SFr 105,560    
Other service income 1,870   1,870 1,430  
Revenue and other operating income 36,375 115,277 107,430 350,187  
Long-lived assets 5,848,435   5,848,435   SFr 7,136,940
Operating costs 769,273 1,014,593 1,446,590 2,037,595  
Capital expenditure 0 0 0 0  
Switzerland          
Segments          
Long-lived assets 5,848,099   5,848,099   7,136,602
Operating costs 765,310 1,010,390 1,439,158 2,031,464  
United States of America          
Segments          
Operating costs 2,840 2,371 5,155 4,017  
France          
Segments          
Long-lived assets 336   336   SFr 338
Operating costs 1,123 1,832 2,277 2,114  
Indivior PLC          
Segments          
Revenue and other operating income   SFr 115,277   348,757  
Neurosterix Group          
Segments          
Revenue and other operating income 34,505   105,560    
Other counterparties          
Segments          
Revenue and other operating income SFr 1,870   SFr 1,870 SFr 1,430